( NYSE:ABT )

News from Abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 20, 2017, 18:00 ET New Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic...


Jan 18, 2017, 08:00 ET Abbott Announces European Launch of the Proclaim™ DRG Neurostimulation System for the Management of Chronic Neuropathic Pain

Abbott (NYSE: ABT) today announced the European launch of the new Proclaim™ DRG Neurostimulation System, designed to deliver dorsal root ganglion...


Jan 17, 2017, 08:00 ET New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation

New data published in the January edition of Pain has confirmed the superiority of Abbott's dorsal root ganglion (DRG) stimulation therapy over...


Jan 12, 2017, 16:00 ET Abbott Announces U.S. Launch and First Commercial Use of the New EnSite™ Precision Cardiac Mapping System

Abbott (NYSE: ABT) announced today the U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping system and Advisor™...


Jan 11, 2017, 00:00 ET Abbott Obtient la Certification CE pour ses Systèmes de Diagnostic de la Série « Alinity ci »

LA NOUVELLE GÉNÉRATION DE SYSTÈMES HARMONISÉS, ASSOCIÉE AUX SERVICES PROFESSIONNELS ALINIQ LANCÉS RÉCEMMENT, APPORTENT UNE SOLUTION UNIQUE POUR...


Jan 10, 2017, 07:00 ET Abbott Announces CE Mark for its "Alinity s" Blood and Plasma Screening System

Abbott (NYSE: ABT) announced today its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other...


Jan 10, 2017, 07:00 ET Abbott Announces CE Mark for its Alinity ci-series Diagnostic Systems

Abbott (NYSE: ABT) announced today its Alinity™ ci-series instruments for clinical chemistry and immunoassay diagnostics have obtained CE Mark and...


Jan 04, 2017, 16:30 ET Abbott Completes the Acquisition of St. Jude Medical

Abbott (NYSE: ABT) announced today it has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical...


Dec 30, 2016, 12:30 ET Abbott Acquisition of St. Jude Medical Set to Close on January 4, 2017

Abbott (NYSE: ABT) announced today it intends to close the acquisition of St. Jude Medical, Inc., on Wednesday, Jan. 4, 2017. The announcement...


Dec 21, 2016, 09:00 ET Abbott Hosts Conference Call for Fourth-Quarter Earnings

Abbott (NYSE: ABT) will announce its fourth-quarter and full-year 2016 financial results on Wednesday, Jan. 25, 2017, before the market opens....


Dec 19, 2016, 09:00 ET Abbott to Present at J.P. Morgan Healthcare Conference

Abbott (NYSE: ABT) will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2017. Brian Yoor, senior vice president,...


Dec 09, 2016, 10:25 ET Abbott Raising Quarterly Dividend for 45th Straight Year

The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 26.5 cents per share from 26 cents per...


Dec 07, 2016, 11:14 ET Abbott Seeks to Terminate Alere Acquisition

Abbott (NYSE: ABT) has filed a complaint to terminate its proposed acquisition of Alere based on the substantial loss in Alere's value following...


Dec 06, 2016, 08:00 ET Study: Hospital Nutrition Program Shortens Patient Stays and Reduces Readmissions

While proper nutrition is vital to staying healthy, its importance becomes more critical for patients recovering in the hospital. A new study by...


Nov 30, 2016, 07:00 ET Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform

Abbott (NYSE: ABT) announced today its i-STAT® Alinity™ System, an innovative, handheld blood testing platform, received CE Mark and is now for...


Nov 07, 2016, 07:00 ET Abbott's Absorb™ Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan

Abbott (NYSE: ABT) announced today that the Ministry of Health, Labor and Welfare (MHLW) in Japan has approved the company's Absorb bioresorbable...


Oct 27, 2016, 14:00 ET A Great Place to Work, According to Science

Don't trust us, trust Science: Abbott is among the best science-based companies to work for in the world. Experience the interactive Multimedia...


Oct 26, 2016, 14:00 ET New Study: Babies Fed Infant Formula with 2'-FL Human Milk Oligosaccharide+ Had Immune Response More Like Breastfed Babies

Good nutrition helps build the foundation for a child's ability to learn, grow and thrive. For babies, the best nutrition is breast milk – there's...


Oct 19, 2016, 07:45 ET Abbott Reports Third-Quarter 2016 Results

Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2016. - Third-quarter worldwide sales of $5.3...


Oct 18, 2016, 08:00 ET St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation

Abbott (NYSE: ABT) and St. Jude Medical, Inc. (NYSE: STJ) announced today an agreement in principle to sell certain products to Terumo Corporation....


Sep 28, 2016, 09:00 ET Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's FreeStyle Libre Pro system, a...


Sep 21, 2016, 14:00 ET Malnutrition Adds $15.5 Billion Annually to Direct U.S. Medical Costs

Healthcare spending in the U.S. is higher than any other country,2 and a major contributor of that cost is treating chronic diseases. One barrier...


Sep 21, 2016, 09:00 ET Abbott Hosts Conference Call for Third-Quarter Earnings

 Abbott (NYSE: ABT) will announce its third-quarter 2016 financial results on Wednesday, Oct. 19, 2016, before the market opens. ...


Sep 20, 2016, 09:00 ET Fueling Performance with Fat: EAS® Launches First Ketogenic Meal Replacement For Athletes

 While some endurance, strength and physique athletes try to minimize their intake of fat, others are embracing a high-fat, ketogenic nutrition...


Sep 16, 2016, 15:00 ET Abbott to Sell Abbott Medical Optics to Johnson & Johnson for $4.325 Billion

Abbott (NYSE: ABT) announced today that it will sell Abbott Medical Optics, its vision care business, to Johnson & Johnson for $4.325 billion...